Skip to main content

Advertisement

Log in

Management of Recurrent Rectal Cancer

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Here we present a concise review on the evaluation and management of locally recurrent rectal cancer, which despite marked reductions in the rate of recurrent rectal cancer remains an important problem.

Methods

This educational review discusses the diagnosis, evaluation, and management of recurrent rectal cancer.

Results

Despite improvements in both the neoadjuvant and surgical management of rectal cancer, local recurrence is still an important problem, with documented recurrence rates of 4% to 8%. The local management of recurrence requires a team of specialist. Accurate detection and diagnosis followed by chemoradiotherapy and surgical resection may result in 5-year survival rates of up to 35%.

Conclusions

We discuss the diagnosis, evaluation, and management of locally recurrent rectal cancer. Locally recurrent rectal cancer can be successfully managed with multimodal therapy leading to successful palliation and often cure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

References

  1. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 1998;133:894–9.

    Article  CAS  PubMed  Google Scholar 

  2. Davies M, Harries D, Hirst G, et al. Local recurrence after abdomino-perineal resection. Colorectal Dis 2009;11:39–43.

    Article  CAS  PubMed  Google Scholar 

  3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638–46.

    Article  CAS  PubMed  Google Scholar 

  4. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40.

    Article  CAS  PubMed  Google Scholar 

  5. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974;34:1278–92.

    Article  CAS  PubMed  Google Scholar 

  6. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007;14:447–54.

    Article  CAS  PubMed  Google Scholar 

  7. Bakx R, Visser O, Josso J, et al. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol 2008;14:6018–23.

    Article  PubMed  Google Scholar 

  8. Kim YW, Kim NK, Min BS, et al. Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients. J Surg Oncol 2009;99:58–64.

    Article  PubMed  Google Scholar 

  9. Dent OF, Haboubi N, Chapuis PH, et al. Assessing the evidence for an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Colorectal Dis 2007;9:112–21.

    Article  CAS  PubMed  Google Scholar 

  10. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449–57.

    Article  PubMed  Google Scholar 

  11. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350–7.

    Article  PubMed  Google Scholar 

  12. Shirouzu K, Isomoto H, Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 1995;76:388–92.

    Article  CAS  PubMed  Google Scholar 

  13. Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003;10:80–5.

    Article  PubMed  Google Scholar 

  14. Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001;19:3895–902.

    CAS  PubMed  Google Scholar 

  15. Ogiwara H, Nakamura T, Baba S. Variables related to risk of recurrence in rectal cancer without lymph node metastasis. Ann Surg Oncol 1994;1:99–104.

    Article  CAS  PubMed  Google Scholar 

  16. Tilney HS, Tekkis PP, Sains PS, Constantinides VA, Heriot AG. Factors affecting circumferential resection margin involvement after rectal cancer excision. Dis Colon Rectum 2007;50:29–36.

    Article  PubMed  Google Scholar 

  17. Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004;47:1599–606.

    Article  PubMed  Google Scholar 

  18. Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008;51:284–91.

    Article  PubMed  Google Scholar 

  19. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237:502–8.

    Article  PubMed  Google Scholar 

  20. Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999;42:886–93.

    Article  CAS  PubMed  Google Scholar 

  21. Beets-Tan RG, Beets GL, Borstlap AC, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging 2000;25:533–41.

    Article  CAS  PubMed  Google Scholar 

  22. Messiou C, Chalmers AG, Boyle K, Wilson D, Sagar P. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 2008;81(966):468–73.

    Article  CAS  PubMed  Google Scholar 

  23. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005;48:722–8.

    Article  PubMed  Google Scholar 

  24. Messiou C, Chalmers A, Boyle K, Sagar P. Surgery for recurrent rectal carcinoma: the role of preoperative magnetic resonance imaging. Clin Radiol 2006;61:250–8.

    Article  CAS  PubMed  Google Scholar 

  25. Chessin DB, Kiran RP, Akhurst T, Guillem JG. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg 2005;201:948–56.

    Article  PubMed  Google Scholar 

  26. Watson AJ, Lolohea S, Robertson GM, Frizelle FA. The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 2007;50:102–14.

    Article  CAS  PubMed  Google Scholar 

  27. Faneyte IF, Dresen RC, Edelbroek MA, Nieuwenhuijzen GA, Rutten HJ. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer. Dig Surg 2008;25:202–7.

    Article  PubMed  Google Scholar 

  28. Schurr P, Lentz E, Block S, et al. Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience. J Gastrointest Surg 2008;12:1232–8.

    Article  PubMed  Google Scholar 

  29. Yiu R, Wong SK, Cromwell J, et al. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum 2001;44:1676–81.

    Article  CAS  PubMed  Google Scholar 

  30. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004;47:2047–53.

    Article  PubMed  Google Scholar 

  31. Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995;75:939–52.

    Article  CAS  PubMed  Google Scholar 

  32. Dresen RC, Gosens MJ, Martijn H, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008;15:1937–47.

    Article  PubMed  Google Scholar 

  33. Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol 2005;23:5620–7.

    Article  CAS  PubMed  Google Scholar 

  34. Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 2008;15:2661–7.

    Article  PubMed  Google Scholar 

  35. Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002;95:1144–50.

    Article  PubMed  Google Scholar 

  36. Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys 2006;64:1129–39.

    PubMed  Google Scholar 

  37. Gunderson LL, Nelson H, Martenson JA, et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum 1996;39:1379–95.

    Article  CAS  PubMed  Google Scholar 

  38. Lanciano RM, Calkins AR, Wolkov HB, et al. A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a Radiation Therapy Oncology Group (RTOG) study. J Surg Oncol 1993;53:20–9.

    Article  CAS  PubMed  Google Scholar 

  39. Mannaerts GH, Rutten HJ, Martijn H, Hanssens PE, Wiggers T. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 2001;44:1749–58.

    Article  CAS  PubMed  Google Scholar 

  40. Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002;45:585–92.

    Article  PubMed  Google Scholar 

  41. Nuyttens JJ, Kolkman-Deurloo IK, Vermaas M, et al. High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2004;58:106–12.

    Article  PubMed  Google Scholar 

  42. Mannaerts GH, Martijn H, Crommelin MA, et al. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:297–308.

    CAS  PubMed  Google Scholar 

  43. Lindel K, Willett CG, Shellito PC, et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol 2001;58:83–7.

    Article  CAS  PubMed  Google Scholar 

  44. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002;62:207–13.

    Article  PubMed  Google Scholar 

  45. Harrison LB, Minsky BD, Enker WE, et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:325–30.

    CAS  PubMed  Google Scholar 

  46. Alektiar KM, Zelefsky MJ, Paty PB, et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 2000;48:219–26.

    Article  CAS  PubMed  Google Scholar 

  47. Gunderson LL, Martin JK, Beart RW, et al. Intraoperative and external beam irradiation for locally advanced colorectal cancer. Ann Surg 1988;207:52–60.

    Article  CAS  PubMed  Google Scholar 

  48. Saito N, Koda K, Takiguchi N, et al. Surgery for local pelvic recurrence after resection of rectal cancer. Int J Colorectal Dis 1998;13:32–8.

    Article  CAS  PubMed  Google Scholar 

  49. Saito N, Koda K, Takiguchi N, et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003;20:192–9.

    Article  PubMed  Google Scholar 

  50. Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001;18:355–62.

    Article  CAS  PubMed  Google Scholar 

  51. Bullard KM, Trudel JL, Baxter NN, Rothenberger DA. Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum 2005;48:438–43.

    Article  PubMed  Google Scholar 

  52. Artioukh DY, Smith RA, Gokul K. Risk factors for impaired healing of the perineal wound after abdominoperineal resection of rectum for carcinoma. Colorectal Dis 2007;9:362–7.

    Article  CAS  PubMed  Google Scholar 

  53. Butler CE, Gundeslioglu AO, Rodriguez-Bigas MA. Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg 2008;206:694–703.

    Article  PubMed  Google Scholar 

  54. Abbott DE, Halverson AL, Wayne JD, et al. The oblique rectus abdominal myocutaneous flap for complex pelvic wound reconstruction. Dis Colon Rectum 2008;51:1237–41.

    Article  PubMed  Google Scholar 

  55. Wille-Jorgensen P, Pilsgaard B, Moller P. Reconstruction of the pelvic floor with a biological mesh after abdominoperineal excision for rectal cancer. Int J Colorectal Dis 2009;24:323–5.

    Article  PubMed  Google Scholar 

  56. Willett CG, Gunderson LL. Palliative treatment of rectal cancer: is radiotherapy alone a good option? J Gastrointest Surg 2004;8:277–9.

    Article  PubMed  Google Scholar 

  57. Hunerbein M, Krause M, Moesta KT, Rau B, Schlag PM. Palliation of malignant rectal obstruction with self-expanding metal stents. Surgery 2005;137:42–7.

    Article  PubMed  Google Scholar 

  58. Song HY, Kim JH, Kim KR, et al. Malignant rectal obstruction within 5 cm of the anal verge: is there a role for expandable metallic stent placement? Gastrointest Endosc 2008;68:713–20.

    Article  PubMed  Google Scholar 

  59. Nash GM, Saltz LB, Kemeny NE, et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002;9:954–60.

    Article  PubMed  Google Scholar 

  60. Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005;48:929–37.

    Article  PubMed  Google Scholar 

  61. Wiig JN, Poulsen JP, Larsen S, et al. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002;168:42–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan Efron MD, FACS, FASCRS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouchard, P., Efron, J. Management of Recurrent Rectal Cancer. Ann Surg Oncol 17, 1343–1356 (2010). https://doi.org/10.1245/s10434-009-0861-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0861-2

Keywords

Navigation